DekaBank Deutsche Girozentrale’s Elevance Health ELV Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$99.4M	Hold	343,263	–	–	0.17%	135
2026 Q1	$101M	Hold	343,263	–	–	0.17%	136
2025 Q4	$201M	Hold	343,263	–	–	0.35%	64
2025 Q3	$110M	Hold	343,263	–	–	0.18%	125
2025 Q2	$131M	Sell	343,263 -12,706	-4%	-$5.11M	0.23%	104
2025 Q1	$152M	Buy	355,969 +12,706	+4%	+$5.1M	0.3%	75
2024 Q4	$126M	Hold	343,263	–	–	0.23%	101
2024 Q3	$179M	Sell	343,263 -923	-0.3%	-$493K	0.33%	74
2024 Q2	$185M	Sell	344,186 -11,783	-3%	-$6.23M	0.33%	67
2024 Q1	$184M	Buy	355,969 +15,537	+5%	+$7.73M	0.34%	67
2023 Q4	$159M	Buy	340,432 +296	+0.1%	+$137K	0.33%	74
2023 Q3	$152M	Buy	340,136 +7,028	+2%	+$3.19M	0.35%	65
2023 Q2	$147M	Buy	333,108 +13,767	+4%	+$6.35M	0.33%	69
2023 Q1	$146M	Buy	319,341 +3,324	+1%	+$1.58M	0.37%	62
2022 Q4	$160M	Buy	316,017 +31,654	+11%	+$16.1M	0.42%	54
2022 Q3	$129M	Buy	284,363 +17,838	+7%	+$8.54M	0.38%	58
2022 Q2	$129M	Buy	266,525 +43,291	+19%	+$21.4M	0.37%	61
2022 Q1	$112M	Buy	223,234 +92,650	+71%	+$42.4M	0.27%	89
2021 Q4	$60.6M	Buy	130,584 +12,101	+10%	+$5.09M	0.15%	150
2021 Q3	$45.7M	Buy	118,483 +22,245	+23%	+$8.45M	0.13%	172
2021 Q2	$36.3M	Buy	96,238 +8,944	+10%	+$3.42M	0.11%	196
2021 Q1	$31.5M	Sell	87,294 -1,413	-2%	-$454K	0.1%	196
2020 Q4	$27.7M	Sell	88,707 -3,213	-3%	-$986K	0.1%	196
2020 Q3	$23.5M	Buy	91,920 +54,964	+149%	+$14.8M	0.1%	180
2020 Q2	$9.48M	Buy	36,956 +25	+0.1%	+$6.67K	0.06%	215
2020 Q1	$8.43M	Buy	36,931 +894	+2%	+$244K	0.06%	201
2019 Q4	$10.9M	Sell	36,037 -78,903	-69%	-$21.7M	0.07%	213
2019 Q3	$27.5M	Sell	114,940 -51,395	-31%	-$14.1M	0.17%	131
2019 Q2	$47.1M	Buy	166,335 +52,719	+46%	+$14.4M	0.24%	108
2019 Q1	$30.4M	Sell	113,616 -8,264	-7%	-$2.39M	0.18%	144
2018 Q4	$32M	Buy	121,880 +8,264	+7%	+$2.27M	0.21%	108
2018 Q3	$30.4M	Buy	113,616 +2,493	+2%	+$647K	0.18%	145
2018 Q2	$26.8M	Sell	111,123 -19,107	-15%	-$4.42M	0.17%	151
2018 Q1	$29.1M	Sell	130,230 -31,863	-20%	-$7.48M	0.2%	131
2017 Q4	$31.6M	Sell	162,093 -345	-0.2%	-$73.5K	0.24%	103
2017 Q3	$31.6M	Sell	162,438 -93,530	-37%	-$17.8M	0.25%	101
2017 Q2	$48.1M	Buy	255,968 +10,626	+4%	+$1.91M	0.38%	68
2017 Q1	$41M	Buy	+245,342	New	+$39M	0.38%	69
2016 Q3	–	Sell	-177,198	Closed	-$23.3M	–	975
2016 Q2	$23.3M	Buy	177,198 +72,482	+69%	+$9.92M	0.27%	89
2016 Q1	$14.5M	Buy	104,716 +9,643	+10%	+$1.29M	0.17%	129
2015 Q4	$13.5M	Buy	95,073 +13,571	+17%	+$1.87M	0.15%	138
2015 Q3	$11.3M	Sell	81,502 -85,013	-51%	-$12.8M	0.14%	154
2015 Q2	$27.4M	Buy	166,515 +11,535	+7%	+$1.84M	0.32%	63
2015 Q1	$24.1M	Sell	154,980 -891	-0.6%	-$127K	0.3%	69
2014 Q4	$19.8M	Buy	155,871 +4,418	+3%	+$546K	0.25%	92
2014 Q3	$18.4M	Buy	151,453 +5,229	+4%	+$600K	0.25%	93
2014 Q2	$15.7M	Buy	146,224 +3,409	+2%	+$351K	0.24%	101
2014 Q1	$14.3M	Buy	142,815 +23,926	+20%	+$2.16M	0.23%	99
2013 Q4	$11M	Sell	118,889 -2,882	-2%	-$256K	0.18%	117
2013 Q3	$10.1M	Sell	121,771 -3,545	-3%	-$304K	0.18%	114
2013 Q2	$10.2M	Buy	+125,316	New	+$9.38M	0.2%	100

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ELV Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Elevance Health (ELV) position steady in Q2 2026 at 343,263 shares worth $99.4M. The position accounts for 0.17% of the portfolio, ranked #135.

DekaBank Deutsche Girozentrale first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $201M in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

DekaBank Deutsche Girozentrale held 343,263 shares of Elevance Health worth $99.4M as of Q2 2026.
DekaBank Deutsche Girozentrale left its Elevance Health share count unchanged in Q2 2026.
Elevance Health made up 0.17% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #135 holding.
DekaBank Deutsche Girozentrale first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
DekaBank Deutsche Girozentrale's Elevance Health position peaked at $201M in Q4 2025.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.